Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age - Related Macular Degeneration”

2,027 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,027 results

Not applicableStudy completedNCT02028351
What this trial is testing

Vision Measured by the Vimetrics CVA Compared With Chart Testing Under Similar Luminance and Contrast Conditions

Who this might be right for
Refractive ErrorCataractMaculopathy
Sinclair Technologies, LLC 150
Testing effectiveness (Phase 2)Study completedNCT00006202
What this trial is testing

Lutein for Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
National Eye Institute (NEI) 45
Large-scale testing (Phase 3)Ended earlyNCT00619229
What this trial is testing

Alprostadil in Maculopathy Study (AIMS)

Who this might be right for
Macular Degeneration
UCB Pharma 37
Not applicableStudy completedNCT01350323
What this trial is testing

Aqueous Vascular Endothelial Growth Factor (VEGF) Levels in Type 3 Neovascularization

Who this might be right for
Age-related Macular Degeneration
University of Molise 33
Testing effectiveness (Phase 2)Study completedNCT01213082
What this trial is testing

ProspectiveTrial of Proton Beam Combined With Anti-VEGF Therapy for Exudative Age-related Macular Degeneration (AMD)

Who this might be right for
Exudative Age-related Macular Degeneration
University of California, Davis 34
Post-approval studies (Phase 4)Study completedNCT05832996
What this trial is testing

Cool vs Room-temperature Artificial Tears

Who this might be right for
Diabetic Retinopathy With Macular Edema of Both Eyes (Diagnosis)Central Retinal Vein Occlusion With Macular EdemaExudative Age-Related Macular Degeneration, Unspecified Eye+4 more
University of Iowa 124
Not applicableStudy completedNCT02464956
What this trial is testing

Production of iPSC Derived RPE Cells for Transplantation in AMD

Who this might be right for
Age Related Macular Degeneration (AMD)
Moorfields Eye Hospital NHS Foundation Trust 3
Not applicableActive Not RecruitingNCT07390253
What this trial is testing

Switch From 2mg Aflibercept to 8mg Aflibercept in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular (Wet) Age-Related Macular Degeneration
Vienna Institute for Research in Ocular Surgery 50
Not applicableEnded earlyNCT04468373
What this trial is testing

Study of WA-NG (NG-IMT) Telescope Prosthesis in Patients With End-stage Age-related Macular Degeneration

Who this might be right for
Age Related Macular Degeneration
VisionCare, Inc. 9
Not applicableStudy completedNCT03438669
What this trial is testing

Correlation Between Visual Acuity Measurements, Quality of Life and Morphological Parameters in Wet AMD Patients

Who this might be right for
Macular Degeneration
Dr. med. Katja Hatz 53
Post-approval studies (Phase 4)Ended earlyNCT02002377
What this trial is testing

Intravitreal Aflibercept in Wet Age Related Macular Degeneration Patients With an Incomplete Response to Routine Ranibizumab Injections

Who this might be right for
Age Related Macular Degeneration
Unity Health Toronto 23
Early research (Phase 1)UnknownNCT04120311
What this trial is testing

Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole

Who this might be right for
Macular EdemaRadiation RetinopathyBranch Retinal Vein Occlusion+4 more
Targeted Therapy Technologies, LLC 2
Testing effectiveness (Phase 2)Study completedNCT05403749
What this trial is testing

Longer Interval of IVT IBI302 in Subjects With nAMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Innovent Biologics (Suzhou) Co. Ltd. 132
Large-scale testing (Phase 3)Study completedNCT02611778
What this trial is testing

Efficacy and Safety of the Biosimilar Ranibizumab FYB201 in Comparison to Lucentis in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration (AMD)
Bioeq GmbH 712
Post-approval studies (Phase 4)Study completedNCT02432547
What this trial is testing

Laser Therapy Combined With Intravitreal Aflibercept vs Intravitreal Aflibercept Monotherapy (LADAMO)

Who this might be right for
Diabetic Retinopathy
University of Sydney 48
Large-scale testing (Phase 3)UnknownNCT00559715
What this trial is testing

Prevention of Vision Loss in Patients With Age-Related Macular Degeneration (AMD) by Intravitreal Injection of Bevacizumab and Ranibizumab

Who this might be right for
Age-Related Neovascular Macular Degeneration
Klinikum Bremen-Mitte, gGmbH 366
Not applicableStudy completedNCT01698749
What this trial is testing

Effect of Intravitreal Long Acting Dexamethasone Implant, Ozurdex in Patients With Diabetic Macular Edema

Who this might be right for
Diabetic Macular EdemaMacular Edema, CystoidVision Disorders+1 more
Post Graduate Institute of Medical Education and Research, Chandigarh 61
Testing effectiveness (Phase 2)UnknownNCT02749734
What this trial is testing

Clinical Study of Subretinal Transplantation of Human Embryo Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Macular Degeneration Diseases

Who this might be right for
Macular DegenerationStargardt's Macular Dystrophy
Southwest Hospital, China 15
Not applicableUnknownNCT04140448
What this trial is testing

Ultra-wide-field Fluorescein Angiography in Patients With Macular Edema Secondary to Retinal Vein Occlusion

Who this might be right for
Retinal Vein OcclusionMacular Edema
Renmin Hospital of Wuhan University 60
Large-scale testing (Phase 3)Active Not RecruitingNCT06491914
What this trial is testing

A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME)

Who this might be right for
Neovascular Age-Related Macular DegenerationDiabetic Macular Edema
Regeneron Pharmaceuticals 1,118
Load More Results